Using hydrogels to deliver healing factors for better bone regeneration
Granular hydrogels for the controlled delivery of immunomodulatory and angiogenic extracellular vesicles to enhance bone tissue regeneration
This study is looking at how special gels can help heal big bone injuries by delivering tiny healing particles that reduce swelling and help grow new blood vessels, making it easier for your body to repair itself.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-10998711 on NIH RePORTER |
What this research studies
This research focuses on improving the healing of large bone defects caused by injuries or surgeries by using granular hydrogels that can deliver beneficial extracellular vesicles. These vesicles contain factors that help reduce inflammation and promote blood vessel formation, which are crucial for bone healing. The approach involves creating a supportive environment for the body's own cells to regenerate bone tissue effectively. By controlling the release of these healing factors from the hydrogels, the researchers aim to enhance the overall healing process in patients with significant bone loss.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with large bone defects due to trauma, nonunion fractures, or tumor resections.
Not a fit: Patients with small bone injuries or those who do not require surgical intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with large bone defects, reducing the need for traditional grafts and improving recovery outcomes.
How similar studies have performed: Previous research has shown promise in using extracellular vesicles for tissue regeneration, indicating that this approach may be effective.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Friend, Nicole Erin — University of Colorado
- Study coordinator: Friend, Nicole Erin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.